Nice to see someone getting into the science behind oncology .
If a Cancer company were to adopt a potential treatment, then what type of evidence in terms of p-value would they likely demand/ look for? Or is there too many factors involved to determine this?
When comparing different treatments in the same trial, what p-value is considered not strong enough to be statistically significant? what is the reference point?
Cheers,
Nice to see someone getting into the science behind oncology ....
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable